BridgeMD
New treatment option for Schizophrenia Disorders
Official title Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
ClinicalTrials.gov ID: NCT07091344
What this study is testing
- What it's testing
- This study aims to evaluate the relationship between cognitive, metacognitive and social cognition variables in patients with psychosis undergoing VR-based Avatar Therapy for the treatment of auditory hallucinations. In addition to the primary intervention, participants will be assessed using validated tools for emotion recognition, attributional style, theory of mind, neurocognition, and metacognition.
- Time commitment: about 12 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \ \ \ \
- Adults aged 18 years or older.
- Diagnosis of schizophrenia spectrum disorder according to DSM-5 criteria.
- Experience of persistent auditory hallucinations for at least 3 months (PANSS hallucination score ≥ 3).
- Stable medication dosage for at least 4 weeks prior to recruitment.
You likely can't join if
- Inability to identify a dominant voice for Avatar Therapy intervention.
- Intellectual disability based on medical history.
- Active substance abuse.
- Central nervous system injury or neurological disorders affecting cognitive performance.
- Severe visual impairment that precludes the use of VR technology.
- Aversion to virtual reality or prior experience of simulator sickness.
See the full eligibility criteria
- \ \ \ \
- Adults aged 18 years or older.
- Diagnosis of schizophrenia spectrum disorder according to DSM-5 criteria.
- Experience of persistent auditory hallucinations for at least 3 months (PANSS hallucination score ≥ 3).
- Stable medication dosage for at least 4 weeks prior to recruitment.
- Fluent in the spoken language of the study site (Spanish).
- Able to provide informed consent.
- Regular psychiatric follow-up care. \ \
- Inability to identify a dominant voice for Avatar Therapy intervention.
- Intellectual disability based on medical history.
- Active substance abuse.
- Central nervous system injury or neurological disorders affecting cognitive performance.
- Severe visual impairment that precludes the use of VR technology.
- Aversion to virtual reality or prior experience of simulator sickness.
- Current suicidal ideation or risk.
- Lack of cooperation or inability to comply with study procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Catalonia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Catalonia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.